Traws Pharma, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Leaman John Harold | — | Award / Grant | 4,058 | — | — | 4,058 | Dec 12, 2025 |
| Clarke Trafford | — | Award / Grant | 6,157 | — | — | 6,157 | Dec 12, 2025 |
| CAUTREELS WERNER | — | Award / Grant | 4,874 | — | — | 109,222 | Dec 12, 2025 |
| Shoemaker Mary Teresa | — | Award / Grant | 6,157 | — | — | 6,292 | Dec 12, 2025 |
| STOVER JACK E | — | Award / Grant | 6,157 | — | — | 6,165 | Dec 12, 2025 |
| Dukes Iain D. | Chief Executive Officer | Award / Grant | 36,943 | — | — | 171,130 | Dec 12, 2025 |
| Pauza Charles David | Chief Science Officer Virology | Award / Grant | 18,471 | — | — | 115,971 | Dec 12, 2025 |
| Redfield Robert | Chief Medical Officer | Award / Grant | 16,419 | — | — | 113,919 | Dec 12, 2025 |
| Savchuk Nikolay | Chief Operating Officer | Award / Grant | 16,419 | — | — | 150,606 | Dec 12, 2025 |
| Savchuk Nikolay | Chief Operating Officer | Other | 605,531 | — | — | — | Apr 2, 2025 |
| CAUTREELS WERNER | Chief Executive Officer | Option Exercise | 96,348 | $0.01 | $963 | 104,348 | Feb 18, 2025 |
| Guerin Mark Patrick | CFO | Option Exercise | 5,500 | — | — | 41,476 | Jun 18, 2024 |
| Redfield Robert | Acting Chief Medical Officer | Award / Grant | 97,500 | — | — | 97,500 | Apr 1, 2024 |
| Pauza Charles David | Chief Science Officer Virology | Award / Grant | 97,500 | — | — | 97,500 | Apr 1, 2024 |
| CAUTREELS WERNER | Chief Executive Officer | Award / Grant | 200,000 | — | — | 200,000 | Apr 1, 2024 |
| Savchuk Nikolay | Chief Operating Officer | Award / Grant | 67,550 | — | — | 134,187 | Apr 1, 2024 |
| Dukes Iain D. | Executive Chairman | Award / Grant | 66,687 | — | — | 66,687 | Apr 1, 2024 |
| Dukes Iain D. | Executive Chairman | Award / Grant | 67,500 | — | — | 134,187 | Apr 1, 2024 |
| Savchuk Nikolay | Chief Operating Officer | Award / Grant | 67,500 | — | — | 134,187 | Apr 1, 2024 |
| Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Option Exercise | 23,111 | — | — | 83,519 | Mar 14, 2024 |
| Guerin Mark Patrick | CFO AND COO | Tax Withholding | 2,591 | $0.90 | $2,332 | 35,976 | Mar 13, 2024 |
| Guerin Mark Patrick | CFO AND COO | Option Exercise | 6,900 | — | — | 32,344 | Feb 7, 2024 |
| Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Option Exercise | 21,320 | — | — | 69,620 | Feb 7, 2024 |
| Guerin Mark Patrick | CFO AND COO | Tax Withholding | 1,422 | $1.02 | $1,450 | 25,444 | Aug 2, 2023 |
| Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Tax Withholding | 4,744 | $1.01 | $4,791 | 48,300 | Aug 2, 2023 |
| Guerin Mark Patrick | CFO AND COO | Tax Withholding | 1,575 | $1.14 | $1,795 | 22,116 | Jun 12, 2023 |
| Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Tax Withholding | 6,977 | $1.36 | $9,489 | 40,477 | Feb 7, 2023 |
| Gelder Mark S. MD | CHIEF MEDICAL OFFICER | Option Exercise | 5,833 | — | — | 11,729 | Feb 7, 2023 |
| Guerin Mark Patrick | CFO AND COO | Option Exercise | 6,900 | — | — | 19,976 | Feb 7, 2023 |
| Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Option Exercise | 12,566 | — | — | 30,696 | Aug 3, 2022 |
| Guerin Mark Patrick | CFO AND COO | Tax Withholding | 1,355 | $1.32 | $1,789 | 13,076 | Aug 2, 2022 |
| Gelder Mark S. MD | CHIEF MEDICAL OFFICER | Tax Withholding | 1,135 | $1.32 | $1,498 | 5,896 | Aug 2, 2022 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 1,500 | $1.67 | $2,505 | 24,514 | Jan 28, 2022 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 1,500 | $2.02 | $3,030 | 23,014 | Jan 21, 2022 |
| OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | Purchase | 1,500 | $2.20 | $3,300 | 21,514 | Jan 14, 2022 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 1,500 | $2.39 | $3,585 | 20,014 | Jan 7, 2022 |
| OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | Purchase | 1,000 | $3.16 | $3,160 | 18,514 | Nov 19, 2021 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | X | 5,000 | $3.00 | $15,000 | 17,514 | Nov 18, 2021 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 2,381 | $4.20 | $10,000 | 12,515 | Sep 28, 2021 |
| Gelder Mark S. MD | Chief Medical Officer | Purchase | 2,381 | $4.20 | $10,000 | 2,381 | Sep 28, 2021 |
| Fruchtman Steven M | President, Chief Executive Off | Purchase | 2,381 | $4.20 | $10,000 | 18,130 | Sep 28, 2021 |
| MARINO JAMES J | — | Purchase | 5,952 | $4.20 | $24,998 | 21,334 | Sep 28, 2021 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 12,000 | $1.00 | $12,000 | 152,000 | Feb 16, 2021 |
| Guerin Mark Patrick | Chief Financial Officer | Purchase | 15,000 | $1.00 | $15,000 | 145,213 | Feb 16, 2021 |
| Fruchtman Steven M | President, Chief Executive Off | Purchase | 20,000 | $1.00 | $20,000 | 236,226 | Feb 16, 2021 |
| MARINO JAMES J | — | Purchase | 25,000 | $1.00 | $25,000 | 230,716 | Feb 16, 2021 |
| Shoemaker Mary Teresa | — | Purchase | 13,000 | $1.00 | $13,000 | 50,735 | Feb 16, 2021 |
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Purchase | 30,000 | $0.32 | $9,600 | 140,000 | Dec 11, 2020 |
| Guerin Mark Patrick | Chief Financial Officer | Purchase | 16,755 | $0.26 | $4,356 | 125,599 | Nov 27, 2020 |
| Shoemaker Mary Teresa | — | Purchase | 37,735 | $0.27 | $10,188 | 37,735 | Nov 25, 2020 |